Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	192.12	144.3	156.1	126.35	92.64	73.69
Short-Term Investments	58.38	112.51	19.66	10.32	12.98	11.68
Cash & Short-Term Investments	250.49	256.81	175.76	136.67	105.62	85.36
Cash Growth	-16.47%	46.11%	28.60%	29.40%	23.73%	-4.27%
Accounts Receivable	139.64	114.94	88.8	78.8	66.01	45.38
Other Receivables	5.35	0.53	0.17	0.13	0.39	0.31
Receivables	144.98	115.47	88.98	78.93	66.39	45.69
Inventory	130.32	105.83	103.58	92.81	96.83	110.5
Prepaid Expenses	17.72	9.06	7.56	7.27	6.78	9.54
Restricted Cash	0.24	0.24	0.24	0.24	1.87	1.87
Other Current Assets	2.2	2.2	2.2	2.2	2.2	2.29
Total Current Assets	545.95	489.6	378.32	318.12	279.68	255.24
Property, Plant & Equipment	327.52	315.64	264.57	271.49	280.71	253.55
Long-Term Investments	-	15.21	2.41	3.99	-	-
Goodwill	3.26	3.22	3.13	3.31	3.94	3.63
Other Intangible Assets	591.54	610.08	34.17	35.56	36.68	37.52
Long-Term Deferred Tax Assets	53.25	53.25	38.53	22.4	24.98	25.87
Other Long-Term Assets	23.66	25.91	20.86	16.67	5.25	11.16
Total Assets	1,545	1,513	741.99	671.53	631.24	586.97
Accounts Payable	34.09	25.44	20.5	22.21	24.36	25.06
Accrued Expenses	104.89	180.84	46.19	44.17	45.95	41.51
Current Portion of Long-Term Debt	0.25	0.2	3.05	2.2	12.26	7.74
Current Portion of Leases	4.21	4.14	3	2.98	3.36	3.18
Current Income Taxes Payable	1.28	1.61	4.57	9.08	1.08	2.04
Other Current Liabilities	14.29	13.18	17.55	23.16	25.19	10.48
Total Current Liabilities	159.01	225.41	94.86	103.81	112.2	90.01
Long-Term Debt	595.96	589.2	72.84	74.38	33.58	38.58
Long-Term Leases	29.43	30.1	23.69	25.1	18.07	17.13
Long-Term Deferred Tax Liabilities	-	-	0.14	0.53	0.74	0.87
Other Long-Term Liabilities	30.3	28.78	21.79	22.18	17.92	12.86
Total Liabilities	817.5	873.49	213.33	226.01	182.51	159.44
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	496.43	486.06	455.08	422.42	410.06	367.31
Retained Earnings	530.82	409.27	271.72	180.34	117.77	116.37
Treasury Stock	-290.76	-247.43	-189.52	-150.48	-121.81	-97.63
Comprehensive Income & Other	-8.82	-8.48	-8.62	-6.77	-3.72	-4.69
Total Common Equity	727.68	639.42	528.66	445.52	402.31	381.37
Minority Interest	-	-	-	-	46.42	46.16
Shareholders' Equity	727.68	639.42	528.66	445.52	448.72	427.53
Total Liabilities & Equity	1,545	1,513	741.99	671.53	631.24	586.97
Total Debt	629.85	623.64	102.58	104.66	67.27	66.63
Net Cash (Debt)	-379.36	-366.84	73.18	32.01	38.35	18.74
Net Cash Growth	-	-	128.62%	-16.53%	104.69%	-51.91%
Net Cash Per Share	-7.23	-6.92	1.40	0.64	0.78	0.38
Filing Date Shares Outstanding	48.08	48.1	47.9	48.15	47.43	46.24
Total Common Shares Outstanding	48.37	48.07	48.11	47.71	47.5	46.58
Working Capital	386.94	264.19	283.46	214.31	167.48	165.23
Book Value Per Share	15.04	13.30	10.99	9.34	8.47	8.19
Tangible Book Value	132.88	26.13	491.36	406.65	361.69	340.21
Tangible Book Value Per Share	2.75	0.54	10.21	8.52	7.62	7.30
Land	7.5	7.48	7.45	7.62	7.72	7.6
Buildings	170.2	168.77	130.73	130.58	124.33	117.93
Machinery	313	291.43	237.74	235.26	238.15	186.85
Construction In Progress	28.86	18.68	50.84	41.19	43.98	56.35
Leasehold Improvements	42.01	41.69	31.54	29.22	30.03	29.53

Source: S&P Capital IQ. Standard template. Financial Sources.